Checchi Capital Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $272K | Sell |
|
|||||
|
2025
Q2 | $384K | Buy |
|
|||||
|
2025
Q1 | $433K | Buy |
|
|||||
|
2024
Q4 | $479K | Sell |
|
|||||
|
2024
Q3 | $727K | Sell |
|
|||||
|
2024
Q2 | $728K | Buy |
|
|||||
|
2024
Q1 | $664K | Buy |
|
|||||
|
2023
Q4 | $586K | Buy |
|
|||||
|
2023
Q3 | $511K | Sell |
|
|||||
|
2023
Q2 | $472K | Buy |
|
|||||
|
2023
Q1 | $533K | Buy |
|
|||||
|
2022
Q4 | $455K | Sell |
|
|||||
|
2022
Q3 | $502K | Buy |
|
|||||
|
2022
Q2 | $417K | Buy |
|
|||||
|
2022
Q1 | $418K | Buy |
|
|||||
|
2021
Q4 | $335K | Buy |
|
|||||
|
2021
Q3 | $318K | Buy |
|
|||||
|
2021
Q2 | $281K | Sell |
|
|||||
|
2021
Q1 | $278K | Sell |
|
|||||
|
2020
Q4 | $320K | Sell |
|
|||||
|
2020
Q3 | $398K | Buy |
|
|||||
|
2020
Q2 | $440K | Buy |
|
|||||
|
2020
Q1 | $306K | Sell |
|
|||||
|
2019
Q4 | $245K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $200K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $278K | Buy |
|
|||||
|
2018
Q2 | $230K | Buy |
|
|||||
|
2018
Q1 | $217K | Sell |
|
|||||
|
2017
Q4 | $241K | Buy |
|
|||||
|
2017
Q3 | $241K | Sell |
|
|||||
|
2017
Q2 | $276K | Sell |
|
|||||
|
2017
Q1 | $243K | Buy |
|
|||||
|
2016
Q4 | $219K | Sell |
|
|||||
|
2016
Q3 | $257K | Buy |
|
|||||
|
2016
Q2 | $205K | Sell |
|
|||||
|
2016
Q1 | $219K | Sell |
|
|||||
|
2015
Q4 | $395K | Buy |
|
|||||
|
2015
Q3 | $248K | Buy |
|
|||||
|
2015
Q2 | $268K | Sell |
|
|||||
|
2015
Q1 | $249K | Buy |
|
|||||
|
2014
Q4 | $211K | Buy |
|